Log in to save to my catalogue

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7188667

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

About this item

Full title

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

Publisher

London: Nature Publishing Group UK

Journal title

British journal of cancer, 2020-04, Vol.122 (9), p.1277-1287

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The best-known role of UDP-glucuronosyltransferase enzymes (UGTs) in cancer is the metabolic inactivation of drug therapies. By conjugating glucuronic acid to lipophilic drugs, UGTs impair the biological activity and enhance the water solubility of these agents, driving their elimination. Multiple clinical observations support an expanding role for...

Alternative Titles

Full title

Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progression

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7188667

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7188667

Other Identifiers

ISSN

0007-0920

E-ISSN

1532-1827

DOI

10.1038/s41416-019-0722-0

How to access this item